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Abstract
Introduction Positive end-expiratory pressure (PEEP) improves oxygenation and can prevent ventilator-
induced lung injury in patients with acute respiratory distress syndrome (ARDS). Nevertheless, PEEP
can also induce detrimental effects by its influence on the cardiovascular system. The purpose of this
study was to assess the effects of PEEP on gastric mucosal perfusion while applying a protective
ventilatory strategy in patients with ARDS.
Methods Eight patients were included. A pressure–volume curve was traced and ideal PEEP, defined
as lower inflection point + 2 cmH2O, was determined. Gastric tonometry was measured continuously
(Tonocap). After baseline measurements, 10, 15 and 20 cmH2O PEEP and ideal PEEP were applied
for 30 min each. By the end of each period, hemodynamic, CO2 gap (gastric minus arterial partial
pressures), and ventilatory measurements were performed.
Results PEEP had no effect on CO2 gap (median [range], baseline: 19 [2–30] mmHg; PEEP 10: 19
[0–40] mmHg; PEEP 15: 18 [0–39] mmHg; PEEP 20: 17 [4–39] mmHg; ideal PEEP: 19 [9–39]
mmHg; P = 0.18). Cardiac index also remained unchanged (baseline: 4.6 [2.5–6.3] l min-1 m-2; PEEP
10: 4.5 [2.5–6.9] l min-1 m-2; PEEP 15: 4.3 [2–6.8] l min-1 m-2; PEEP 20: 4.7 [2.4–6.2] l min-1 m-2; ideal
PEEP: 5.1 [2.1–6.3] l min-1 m-2; P = 0.08). One patient did not complete the protocol because of
hypotension.
Conclusion PEEP of 10–20 cmH2O does not affect gastric mucosal perfusion and is hemodynamically
well tolerated in most patients with ARDS, including those receiving adrenergic drugs.
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Introduction
Recent studies have shown that lung protective strategies
using low tidal volumes and high levels of positive end-expira-
tory pressure (PEEP) reduce mortality and are becoming
standard practice in patients with acute respiratory distress
syndrome (ARDS) [1,2].
Although PEEP improves arterial oxygenation, it can adversely
affect systemic hemodynamics, reducing venous return and
cardiac output. These effects are proportional to the PEEP
level. Regional perfusion can also be affected by PEEP, inde-
pendently of cardiac output changes. The splanchnic per-
fusion is particularly sensitive, and any reduction can
compromise its barrier function, promote bacterial transloca-
tion, and contribute to the development of multiple organ fail-
ure [3]. In experimental models, PEEP has markedly
decreased mesenteric and portal blood flow, despite only
moderate reductions in cardiac output [4-8]. Similar results
have been reported in patients without lung injury [9,10].
These effects are usually dose related, becoming more pro-
nounced with PEEP levels around 20 cmH2O.
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Kiefer reported that PEEP did not significantly alter splanchnic
blood flow in six patients with acute lung injury [11]. Neverthe-
less, caution should be exercised in extending these results to
clinical practice, because only hemodynamically stable
patients without adrenergic drugs were studied, and PEEP
levels never exceeded 14 cmH2O [12].
Our aim was to evaluate the effects of PEEP levels up to 20
cmH2O on gastric mucosal perfusion and systemic hemody-
namics in mechanically ventilated patients with ARDS under
hemodynamic support.
Methods
Patients
The study was approved by the Ethics Committee of the Med-
icine Faculty and was performed in the Surgical Intensive Care
Unit of the Catholic University Hospital of Chile.
Adult mechanically ventilated patients were considered eligi-
ble for the study if they met the following criteria for ARDS dur-
ing the 24 hours that preceded the study: acute onset of
respiratory failure; diffuse bilateral infiltrates in the chest radio-
graph; a ratio of partial pressure of O2 (PaO2) to fraction of
inspired oxygen (FiO2) of less than 200 mmHg; and a pulmo-
nary arterial occlusion pressure less than 18 mmHg and no
cardiac failure.
Hemodynamic monitoring included an arterial line and a pul-
monary artery catheter (Baxter Edwards Critical-Care, Irvine,
CA). Patients could be under vasopressor or inotropic sup-
port, but had to be hemodynamically stable for at least 3 hours
before starting the protocol.
Patients were excluded if they had any of the following condi-
tions: pregnancy, pre-existing respiratory dysfunction, cardiac
index of less than 2.5 l min-1 m-2, or were receiving enteral
nutrition.
Interventions
A nasogastric tonometer (TRIP® Tonometry Catheter 14F,
with biofilter connector for TONOCAP™ Monitor) was inserted
into the stomach and connected to air automated tonometry
(TONOCAP™ Monitor; Datex-Engstrom, Helsinki, Finland). All
patients were sedated with midazolam and morphine, and par-
alyzed with rocuronium. Neuromuscular relaxation was meas-
ured by a TOF watch® device. An intravenous 20 mg dose of
famotidine was administered before starting the protocol.
Patients were connected to volume-controlled mechanical
ventilation (Servo 900 C; Siemens, Solna, Sweden). A pres-
sure–volume curve was obtained for each patient by the air-
way occlusion technique [13], and ideal PEEP was defined as
the lower inflection point + 2 cmH2O, or 12 cmH2O if no lower
inflection point was found.
PEEP levels of 10, 15, 20 cmH2O, and ideal PEEP, with tidal
volumes of 8 ml kg-1, were applied in four consecutive 30 min
periods, respectively. Respiratory rate was modified to main-
tain end tidal CO2 within ± 10 mmHg of basal. All patients
were receiving a constant infusion of 6% hetastarch before the
beginning of the study (40–80 ml h-1). Cardiac output was
optimized before and during the trial by determining the respi-
ratory variation of systolic arterial pressure [14]. Whenever the
variation was more than 10% a 100 ml bolus of 6% hetastarch
was infused and the volume status was reassessed. No
change in adrenergic support was allowed during the proto-
col. If hypotension (mean arterial pressure < 65 mmHg) per-
sisted for more than 1 min, the protocol was stopped.
Measurements
At baseline, and at the end of each period, hemodynamic, ven-
tilatory and tonometric measurements were performed, and
arterial blood samples withdrawn. Hemodynamic records
included mean arterial pressure, heart rate, cardiac output,
pulmonary artery occlusion pressure, central venous pressure
and left ventricular stroke work index. Cardiac output was
measured by thermodilution as the average of three values
obtained after injections of 10 ml of 5% dextrose in water at
room temperature. Mean airway pressure, oxygenation index
and PEEP levels were registered. Oxygenation index was cal-
culated as mean airway pressure × FiO2 × 100/PaO2. The
CO2 gap (gastric partial pressure of CO2 [pCO2] minus arte-
rial pCO2) was calculated by comparing simultaneous meas-
urements of tonometric gastric mucosal pCO2 and arterial
pCO2.
Statistical analysis
Results are presented as median and range. The software
Statview 5.0 was used to perform the statistical analysis. Non-
parametric tests were used because of the small sample size.
Data were analyzed with a Friedman test followed by a Wil-
coxon signed-rank test if necessary. Results were considered
statistically significant at P < 0.05.
Results
Eight patients with ARDS were enrolled. They had a median
(range) age of 63.5 years (23–86), and an Acute Physiology
and Chronic Health Evaluation II score of 14 (7–20) at admis-
sion to the intensive care unit. On the day of the study they had
a median Sepsis-related Organ Failure Assessment (SOFA)
[15] score of 10 (7–13). All patients fulfilled criteria for ARDS,
as defined by the inclusion criteria, during the 24 hours before
the study and they had been on mechanical ventilation for 32
(12–72) hours. They were being ventilated with a median
PEEP level of 9 (4–12) cmH2O, they had a PaO2/FiO2 ratio of
235 (144–388) mmHg and their respiratory system compli-
ance was 45 (27–60) ml per cmH2O. Seven patients had sep-
sis (two pneumonia and five extrapulmonary sepsis), and one
a severe thoracic trauma. Of the septic patients, six were inAvailable online http://ccforum.com/content/8/5/R306
R308
septic shock. Characteristics of individual patients are shown
in Table 1.
No changes in cardiac index or in CO2 gap were found at any
of the study periods (Table 2). Oxygenation index, mean arte-
rial pressure, pulmonary mean arterial pressure, pulmonary
artery occlusion pressure, central venous pressure and left
ventricular stroke work index also remained stable through the
study. Only mean airway pressure and PaO2/FiO2 ratio dif-
fered between periods, as expected. Five patients required a
100 ml bolus of hetastarch during the trial; in no patient was it
necessary to repeat it. Individual changes in CO2 gap and car-
diac index are presented in Figs 1 and 2, respectively. At base-
line three patients had already a CO2 gap of more than 20
mmHg. After starting the protocol with 10 cmH2O PEEP,
patient 6, who was previously being ventilated with 4 cmH2O
PEEP, had a further increase in CO2 gap. When PEEP was
increased from 10 to 15 cmH2O, six patients decreased their
CO2 gap and two increased it. When PEEP was increased
from 15 to 20 cmH2O, three patients increased their CO2 gap,
three decreased it and in one patient it remained unchanged.
Patient 4 did not complete the protocol because of moderate
hypotension (mean arterial pressure 60 mmHg) when PEEP
was increased to 20 cmH2O. This patient recovered after an
increased dose of norepinephrine (noradrenaline) and a return
of PEEP to baseline levels.
Six of the eight patients studied survived (75%). The median
length of stay in the intensive care unit was 17 (10–34) days
and the median duration of mechanical ventilation was 9 (5–
34) days.
Discussion
Our results show that high PEEP levels (up to 20 cmH2O) do
not compromise gastric mucosal perfusion, as assessed by
tonometry, and do not affect systemic hemodynamics in most
patients with ARDS. This is consistent with the findings of two
other studies on the effects of PEEP on splanchnic perfusion
in patients with ARDS. Nevertheless, in contrast with our
study, neither of those studies included patients in septic
shock or under adrenergic support [11,16].
Shock and cardiovascular dysfunction are frequently associ-
ated with ARDS. This is an important issue, because hemody-
namic safety concerns could preclude the use of high or
optimal PEEP levels in that setting, even if necessary. A major
finding of our study is that PEEP levels up to 20 cmH2O can
be well tolerated, even in patients with ARDS and septic
shock. Nevertheless, our trial was relatively short and we can-
not exclude the possibility that keeping high PEEP levels for a
longer period might result in increased fluid requirements,
which could be deleterious in the longer term.
Experimental and clinical research has demonstrated that in
mechanically ventilated subjects without lung injury, PEEP
decreases venous return and, secondarily, cardiac output [17-
19]. In addition, Trager and colleagues showed that, in
patients with acute respiratory failure associated with septic
shock, high PEEP levels induced a decrease in cardiac output
[20]. In contrast, we found no decrease in cardiac output in
our patients tested with increasing PEEP levels when fluid
administration was optimized according to respiratory varia-
tion in systolic arterial pressure. A similar result was reported
by Kiefer and colleagues and by Akinci and colleagues
Table 1
Baseline characteristics of the patients
Patient Age 
(years)
Sex Diagnosis APACHE II SOFA PaO2/FiO2 
(mmHg)
pH Bicarbonate 
(mEq/L)
PEEP 
(cmH2O)
Crs (ml/
cmH2O)
LIP 
(cmH2O)
Vasopressors
/inotropesa
Outcome 
(S/NS)
15 5 M H e p a t i c  
lobectomy
14 13 144 7.38 25.4 10 51 10 NA 0.08 S
Dbt 3.3
2 23 F Peritonitis 20 10 388 7.36 23.5 8 32 10 NA 0.12 S
3 32 M Mucormyco
sis and 
sepsis
7 7 282 7.42 21.5 6 60 6 NA 0.09 S
46 8 F A c u t e  
pancreatitis
9 13 208 7.38 20.4 10 40 NL NA 0.2 NS
5 59 F Pneumonia 
and sepsis
16 8 197 7.28 25.5 10 55 NL NA 0.03;
Dp 6.8;
Dbt 3.4
S
6 68 M Thoracic 
trauma
14 10 289 7.36 21.6 4 37 13 NA 0.05 S
7 72 M Sepsis 17 9 263 7.25 13.8 4 50 8 Dbt 5.4 S
8 86 M Pneumonia 
and sepsis
14 12 150 7.37 20.3 12 27 13 NA 0.02 NS
APACHE, Acute Physiology and Chronic Health Evaluation; Crs, Respiratory system compliance; Dbt, dobutamine; Dp, dopamine; LIP, lower 
inflection point; NE, norepinephrine (noradrenaline); NL, no LIP found; NS, not significant; PEEP, positive end-expiratory pressure; S, significant; 
SOFA, Sepsis-related Organ Failure Assessment. aDoses are in µg kg-1 min-1.Critical Care    October 2004  Vol 8 No 5    Bruhn et al.
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[11,16]. Possible explanations for these contradictory results
are a higher rate of fluid administration and the use of lower
tidal volumes in the latter studies. Although we did not deter-
mine the upper inflection point of the pressure–volume curve,
we think that by keeping tidal volume at 8 ml kg-1 any overdis-
tension of the lungs was minimized. Lung volumes are a critical
component of the hemodynamic effects of ventilation [21].
Thus, it seems that it is possible to preserve cardiac output in
patients with ARDS, despite the use of high PEEP levels, by
optimizing fluid administration and limiting tidal volumes.
Gastric mucosal perfusion, as assessed by CO2 gap, also
remained unchanged during the PEEP trial. This is consistent
with the results reported by Kiefer and Akinci in similar studies.
In all these studies cardiac output remained unchanged
[11,16]. In contrast, Trager reported, in a series of septic
shock patients with acute respiratory failure, that an increase
in PEEP from 5 to 15 cmH2O induced a decrease in cardiac
output associated to a decrease in hepatic vein O2 saturation
and in hepatic glucose production [20]. It therefore seems that
by avoiding decreases in cardiac output, splanchnic perfusion
can be preserved in the majority of the patients.
In spite of the fact that no significant changes in CO2 gap or
cardiac index were found during the protocol, when looking at
the individual data certain patients evidenced an adverse
effect when their PEEP level was increased. Patient 4, who
had an extrapulmonary ARDS, presented hypotension when
20 cmH2O PEEP was applied. In this case, no simultaneous
records of cardiac output or CO2 gap could be made for safety
reasons (we immediately proceeded to decrease PEEP level).
Table 2
Respiratory, hemodynamic and tonometric measurements
Parameter Baseline (n = 8) PEEP 10 (n = 8) PEEP 15 (n = 8) PEEP 20 (n = 7) Ideal PEEP (n = 7) P
PEEP (cmH2O) 9 (4–12) 10 15 20 12 (8–15)
Mean airway pressure (cmH2O) 13.2 (8–18.7) 14 (12–17) 19 (17–22.2) 24 (22–26.4) 16.2 (11.5–22.2) 0.0001a
OI (cmH2O per mmHg) 5.3 (2.9–12.4) 7 (3–14.5) 6.7 (4.1–12.3) 7 (5–12.3) 6.6 (2.9–12.3) 0.3
PaO2/FiO2 (mmHg) 235 (144–388) 210 (117–402) 285 (154–412) 333 (196–440) 243 (164–467) 0.0009b
PaCO2 (mmHg) 36 (31–54) 41 (28–63) 42 (31–66) 45 (32–60) 43 (28–52) 0.08
Cardiac index (l min-1 m-2) 4.6 (2.5–6.3) 4.5 (2.5–6.9) 4.3 (2–6.8) 4.7 (2.4–6.2) 5.1 (2.1–6.3) 0.08
LVSWI (g m m-2) 45 (22–71) 43 (22–60) 40 (14–60) 36 (15–58) 42 (14–66) 0.13
MAP (mmHg) 79 (74–103) 81 (69–99) 74 (69–97) 74 (66–93) 73 (69–96) 0.24
PAOP (mmHg) 16 (10–19) 17 (8–22) 17 (11–23) 18 (12–26) 14 (11–23) 0.22
CVP (mmHg) 14 (9–17) 15 (7–19) 15 (9–24) 15 (10–19) 12 (8–18) 0.27
CO2 gap (mmHg) 19 (2–30) 19 (0–40) 18 (0–39) 17 (4–39) 19 (9–39) 0.18
Results are presented as median (range). CVP, central venous pressure; CO2 gap, arterial partial pressure of CO2 [pCO2] minus gastric pCO2; 
FiO2, fraction of inspired oxygen; LVSWI, left ventricular stroke work index; MAP, mean arterial pressure; OI, oxygenation index, defined as mean 
airway pressure × FiO2 × 100/arterial pCO2; PaO2, partial pressure of O2; PaCO2, partial pressure of CO2; PAOP, pulmonary arterial occlusion 
pressure; PEEP, positive end-expiratory pressure. aP < 0.05 for all comparisons except baseline versus PEEP 10 and PEEP 10 versus ideal 
PEEP. bP < 0.05 for all comparisons except baseline versus PEEP 10, baseline versus PEEP 15, baseline versus ideal PEEP, and PEEP 15 
versus ideal PEEP.
Figure 1
Individual changes in CO2 gap (gastric pCO2 minus arterial pCO2) with  different positive end-expiratory pressure levels Individual changes in CO2 gap (gastric pCO2 minus arterial pCO2) with 
different positive end-expiratory pressure levels.
Figure 2
Individual changes in cardiac index with different positive end-expiratory  pressure levels Individual changes in cardiac index with different positive end-expiratory 
pressure levels.
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Patient 6, who had a pulmonary ARDS and who before start-
ing the study had a 30 mmHg CO2 gap while being ventilated
with 4 cmH2O PEEP, presented a further deterioration in CO2
gap after starting the protocol with 10 cmH2O PEEP, which
was not associated with a decrease in cardiac output. There-
after, the CO2 gap remained unchanged despite increasing
PEEP up to 20 cmH2O. These events suggest that not all
patients with ARDS can tolerate high PEEP levels; if required,
careful hemodynamic monitoring including assessment of
regional perfusion should be applied.
One major limitation of our study is the small number of
patients studied. Thus, a type II error cannot be excluded. We
did not perform any a priori power analysis because we had no
estimation of the possible magnitude of the effects that PEEP
could have on gastric tonometry.
Another limitation is the rather moderate severity of ARDS in
our study. Although all patients fulfilled criteria for ARDS dur-
ing the 24 hours that preceded the study, at inclusion their
PaO2/FiO2 ratio and their respiratory system compliance were
only moderately decreased. Two recent papers provide an
explanation for this observation [22,23]. They show in patients
diagnosed with ARDS that after a few hours of treatment with
PEEP or a high FiO2, more than half of the patients present a
PaO2/FiO2 ratio of more than 200 mmHg. In addition, respira-
tory system compliance increased by more than 10 ml per
cmH2O after 6 hours of treatment with PEEP [23]. At inclusion
our patients had already been ventilated with a median PEEP
level of 9 cmH2O for more than 12 hours, which could have
explained the rather improved respiratory performance at
baseline. In any event, this improvement demonstrated a less
severe ARDS. It is possible that more severely compromised
patients might present a lower tolerance to high PEEP levels.
Other limitation is that tonometry was the sole method used to
assess gastric mucosal perfusion. Nevertheless, Elizalde and
colleagues showed that gastric mucosal blood flow, measured
by laser Doppler flowmetry and by reflectance spectrophotom-
etry, is well correlated with gastric intramucosal acidosis in
mechanically ventilated patients [24].
Conclusions
Our study supports the findings of previous studies suggest-
ing that high PEEP levels do not affect splanchnic perfusion
and are hemodynamically well tolerated in most patients with
ARDS. Furthermore, our study shows that gastric mucosal
perfusion can be well preserved while high PEEP levels are
applied even in patients presenting cardiovascular dysfunction
and receiving adrenergic support, which is a frequent occur-
rence in critical care. Nevertheless, two of the eight patients
studied exhibited adverse effects during the PEEP trial, which
highlights the importance of a close monitoring of systemic
and regional perfusion while applying high PEEP levels to
patients with ARDS. Future studies should assess the effects
of PEEP on splanchnic perfusion in a longer term.
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